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DObjectives: Management of intermediate degrees of mitral regurgitation during aortic valve replacement for
aortic stenosis remains controversial. We sought to evaluate the degree of reduction of mitral regurgitation in
patients undergoing aortic valve replacement, as well as a mathematical relationship between aortic valve gra-
dient reduction and the degree of mitral regurgitation decrement.
Methods: We retrospectively analyzed demographic, intraoperative, and echocardiographic data on 802
patients who underwent aortic valve replacement or aortic root replacement between January 2010 and March
2011. A total of 578 patients underwent aortic valve replacement or aortic root replacement without intervention
on the mitral valve. We excluded 88 patients with severe aortic insufficiency, 3 patients who underwent ventric-
ular assist device placement, 4 patients who underwent prior mitral valve replacement, and 21 patients with in-
complete data, yielding 462 patients for analysis. For each patient, the degree of pre- and postoperative mitral
regurgitation was graded on a standard 0 to 4þ scale.
Results: Of the 462 patients, 289 patients had at least mild mitral regurgitation. On average, mitral regurgi-
tation decreased 0.24 degrees per patient for this cohort of 289 patients. Of the 56 patients with at least mod-
erate mitral regurgitation, mitral regurgitation decreased 0.54 degrees per patient. Of 62 patients who
underwent isolated aortic valve replacements, who had at least mild mitral regurgitation, and who had no ev-
idence of structural mitral valve disease, mitral regurgitation decreased 0.24 degrees per patient. Linear re-
gression analysis revealed no relationship between reduction in mitral regurgitation and gradient reduction
across the aortic valve.
Conclusions:Reduction in mitral regurgitation after relief of aortic outflow tract obstruction is modest at best.
Further, the magnitude of gradient change across the aortic valve has little influence on the degree of reduc-
tion in mitral regurgitation. These observations argue at minimum for performing a prospective evaluation of
the clinical benefits of addressing moderate mitral regurgitation at the time of aortic valve intervention and
may support a more aggressive approach to concomitant mitral surgery. (J Thorac Cardiovasc Surg
2013;145:341-8)Coexistent mitral regurgitation (MR) is commonly encoun-
tered in the setting of aortic valve replacement (AVR) for
aortic stenosis.1 Severe MR mandates surgical intervention
at the time of AVR. Some evidence suggests that the pres-
ence of intermediate degrees of MR after AVR carries
a worse prognosis.2-6 However, the mortality of double-
valve surgery may be substantially higher than that of iso-
lated AVR.7,8 Further, it is commonly thought that
functional MR, when present in the setting of severe aortice Division of Cardiovascular Surgery, University of Pennsylvania, Philadel-
Pa.
ures: Authors have nothing to disclose with regard to commercial support.
the 38th Annual Meeting of The Western Thoracic Surgical Association,
, Hawaii, June 27-30, 2012.
d for publication June 23, 2012; revisions received Sept 15, 2012; accepted
blication Oct 22, 2012; available ahead of print Dec 13, 2012.
for reprints: Y. Joseph Woo, MD, Division of Cardiovascular Surgery, Uni-
y of Pennsylvania, 3400 Spruce St, 6 Silverstein Pavilion, Philadelphia, PA
4 (E-mail: joseph.woo@uphs.upenn.edu).
23/$36.00
ht  2013 by The American Association for Thoracic Surgery
.doi.org/10.1016/j.jtcvs.2012.10.043
The Journal of Thoracic and Castenosis, improves significantly after AVR, which
alleviates pressure overload. However, there is substantial
disagreement in the literature over the proportion of
patients who will experience improvement in MR after
AVR, and the degree of improvement that can be expected
is not well defined.1 For these reasons, the appropriate man-
agement of intermediate degrees of MR in the setting of
AVR is undefined and remains controversial, with some au-
thors advocating for a more aggressive surgical ap-
proach2,3,5,8 and others advocating a more conservative
approach.9,10 No randomized controlled clinical trials
that address this issue have been published to date.
Accordingly, after collating existing data in a systematic
fashion, one group concluded that the evidence was
inconclusive to make recommendations regarding surgical
intervention on the mitral valve in the setting of moderate
MR at the time of AVR.11 We sought to define the degree
of improvement in MR that can be expected after AVR in
a contemporary cohort of patients from a single center and
to examine the relationship between change in MR and
change in aortic pressure gradients after AVR.rdiovascular Surgery c Volume 145, Number 2 341
Abbreviations and Acronyms
AVR ¼ aortic valve replacement
CABG ¼ coronary artery bypass grafting
LV ¼ left ventricular
MAC ¼ mitral annular calcification
MR ¼ mitral regurgitation
TAVR ¼ transcatheter aortic valve replacement
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DMATERIALS AND METHODS
Demographic, intraoperative, and echocardiographic data on 802
patients who underwent intervention on the aortic valve (AVR or aortic
root replacement) with or without intervention on the mitral valve
(repair or replacement) between January 2010 and March 2011 were
extracted from the Society of Thoracic Surgeons compliant database
from the University of Pennsylvania. A total of 578 patients underwent
AVR or aortic root replacement without intervention on the mitral
valve. The decision to perform concomitant mitral valve surgical inter-
vention at the time of AVR was made at the discretion of the operating
surgeon. The presence of severe MR typically would prompt repair or
replacement of the mitral valve at the time of AVR. Intervention on the
mitral valve would be considered in the setting of intermediate degrees
of MR in the presence of structural mitral valve disease. An individual
patient’s age and medical comorbidities would be considered in the
ultimate decision as to whether to proceed with intervention on the mi-
tral valve. We excluded 88 patients with severe aortic insufficiency, 3
patients who underwent ventricular assist device placement at the
time of AVR, 4 patients who underwent prior mitral valve replacement,
and 21 patients with incomplete data, yielding 462 patients for
analysis.
Grading of Mitral Regurgitation
Data on MR for each patient were extracted from preoperative and
postoperative echocardiograms. Routine intraoperative transesophageal
echocardiography is used at the University of Pennsylvania, and the in-
traoperative completion transesophageal echocardiography was used as
the postoperative echocardiogram in this study. Measurement of vena
contracta width is the most commonly used method of classifying
MR. MR was numerically graded as follows: none ¼ 0, trace ¼ 0.5,
mild ¼ 1, moderate ¼ 2, moderate-severe ¼ 3, and severe ¼ 4. Interme-
diate degrees were assigned half of a degree. Change in the degree of
MR for each patient was quantitated by subtracting the grade of preop-
erative MR from the degree of postoperative MR. Any patient with any
abnormality of the mitral valve leaflets, the chordae tendineae, the pap-
illary muscles, or the annulus (including mitral annular calcification
[MAC] but excluding pure annular dilatation) was classified as having
structural mitral valve disease. Patients with any degree of leaflet dis-
ease, including tethering, thickening, calcification, or prolapse, were
considered to have a leaflet abnormality. To strictly identify patients
with completely normal mitral valve architecture, even minor abnormal-
ities (eg, small amounts of leaflet calcification) were considered
abnormalities.
Statistical Analysis
Data were expressed as mean standard deviation for continuous vari-
ables and as percentage for categoric variables. Categoric variables were
compared using chi-square tests, and continuous variables were compared
using t tests or rank-sum tests. Simple linear regression was used to evalu-
ate the relationship between change in MR and preoperative mean gradient
across the aortic valve.342 The Journal of Thoracic and Cardiovascular SurgRESULTS
Baseline Patient Characteristics and Operative Data
Baseline characteristics and operative data of this cohort
of 462 patients are presented in Tables 1 and 2. The patients
in this cohort are predominantly elderly (average age,
72.9  10.9 years), Caucasian (90.9%), and male
(58.7%). A large fraction of the patients (81.4%) have hy-
pertension. A majority of these patients (84.0%) had symp-
toms of heart failure preoperatively. New York Heart
Association class 3 symptoms were observed in 37.4% of
patients, and 10.0% of patients had class 4 symptoms. Di-
abetes (29.4%), previous myocardial infarction (19.5%),
cerebrovascular disease (19.9%), and peripheral arterial
disease (16.4%) also were observed in a substantial propor-
tion of the patients. Five percent of the patients in this co-
hort require chronic hemodialysis.
Of the 462 patients in this cohort, a majority (59.3%) un-
derwent AVR only. However, 27.5% of patients underwent
AVR and coronary artery bypass grafting (CABG), 1.9% of
patients underwent AVR/CABG combined with another
procedure (including left atrial appendage excision, Maze
procedure, patent foramen ovale closure, septal myomec-
tomy, and excision of cardiac tumor), and 8.0% of patients
underwent AVR combined with another procedure (includ-
ing ascending aortic aneurysm repair, septal myomectomy,
aortic valve tumor resection, atrial septal defect repair, ex-
cision of left atrial myxoma, Maze procedure, patent fora-
men ovale closure, pacemaker removal, left atrial
appendage excision, and pulmonary embolectomy). Aortic
root replacement was performed in 1.7% of patients, and
aortic root replacement combined with another procedure
(including septal myomectomy, pulmonary artery patch,
CABG) was performed in 1.5% of patients. Because pa-
tients with severe aortic insufficiency were excluded from
this analysis, the predominant indication for AVR in these
cases was aortic stenosis. This was the first cardiac surgery
operation for most of the patients (82.9%) in the cohort, but
first (15.6%), second (1.3%), and third (0.2%) reoperations
also were performed in this series. Most of the cases in this
series (71.9%) were elective, but some (26.4%) were con-
sidered urgent and few (1.7%) were conducted on an emer-
gency basis. Bioprosthetic aortic valves were used in the
majority of cases (93.3%). Mechanical valves were used
less frequently (6.1%), and homografts were rarely used
(0.4%). The average size of the valve implanted was
23.7  2.2 mm.
Fate of Mitral Regurgitation
We next sought to determine the fate of coexistent
MR after AVR. Overall trends in change in MR were ex-
amined by plotting the grade of preoperative and postop-
erative MR for individual patients. As an example, a plot
demonstrating changes in MR after AVR for patients who
underwent AVR only (no other concomitant procedure)ery c February 2013
TABLE 1. Baseline patient characteristics
Age (y) 72.9  10.9
Sex
Male 58.7% (n ¼ 271)
Female 41.3% (n ¼ 191)
Race
Caucasian 90.9% (n ¼ 420)
African American 5.0% (n ¼ 23)
Asian 0.6% (n ¼ 3)
Hispanic 0.4% (n ¼ 2)
Other/unspecified 3.0% (n ¼ 14)
Diabetes 29.4% (n ¼ 135)
Hypertension 81.4% (n ¼ 376)
Previous MI 19.5% (n ¼ 90)
Heart failure 84.0% (n ¼ 388)
NYHA class
1 2.6% (n ¼ 12)
2 34.0% (n ¼ 157)
3 37.4% (n ¼ 173)
4 10.0% (n ¼ 46)
Cerebrovascular disease 19.9% (n ¼ 92)
Peripheral arterial disease 16.4% (n ¼ 76)
Dialysis 5.0% (n ¼ 23)
Creatinine 1.11  0.893
Ejection fraction (n ¼ 454) 56.4%  12.8%
Mean aortic valve gradient (mm Hg, n ¼ 434) 44.6  15.9
Mean pulmonary artery pressure (mm Hg, n ¼ 290) 26.5  9.873
MI, Myocardial infarction; NYHA, New York Heart Association.
FIGURE 1. Trend plot of MR for patients undergoing AVR. The preoper-
ative and postoperative grades of MR for individual patients undergoing
AVR alone (without any concomitant procedure) who had at least mild pre-
operative MR were plotted. Because there is substantial overlap of individ-
ual plots, n values are used to indicate the number of patients represented by
each line. MR, Mitral regurgitation.
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Figure 1 shows, there is substantial variability in the
change in MR after AVR without a clear trend towardTABLE 2. Operative data
Nature of operation
AVR 59.3% (n ¼ 274)
AVR þ CABG 27.5% (n ¼ 127)
AVR þ CABG þ other 1.9% (n ¼ 9)
AVR þ other 8.0% (n ¼ 37)
Aortic root replacement 1.7% (n ¼ 8)
Aortic root replacement þ other 1.5% (n ¼ 7)
Incidence
First cardiac surgery operation 82.9% (n ¼ 383)
First reoperation 15.6% (n ¼ 72)
Second reoperation 1.3% (n ¼ 6)
Third reoperation 0.2% (n ¼ 1)
Urgency
Elective 71.9% (n ¼ 332)
Urgent 26.4% (n ¼ 122)
Emergency 1.7% (n ¼ 8)
Cardiopulmonary bypass time (min) 119  49.6
Crossclamp time (min) 85.8  39.1
Valve type
Bioprosthesis 93.3% (n ¼ 432)
Mechanical 6.1% (n ¼ 28)
Homograft 0.4% (n ¼ 2)
Implant size (mm) 23.7  2.2
AVR, Aortic valve replacement; CABG, coronary artery bypass grafting.
The Journal of Thoracic and Caimprovement. Plots of other subgroups of patients yielded
similar results.
Quantitative Change in Mitral Regurgitation
To quantify the change in MR that occurred in sub-
groups of patients in this cohort, we next used our numeric
scoring system to evaluate the net change in MR in each
group and on average per patient (Tables 3 and 4). The
change in MR per patient was 0.11 degrees in patients
with any preoperative MR,0.24 degrees per patient in pa-
tients with at least mild MR, and 0.54 degrees in patients
with at least moderate MR. Patients who underwent iso-
lated AVR and had at least mild preoperative MR had
downgrading of 0.28 degrees per patient. For patients
who underwent isolated AVR, had at least mild preopera-
tive MR, and had no mitral leaflet or chordal disease, the
average change in MR was 0.26 degrees per patient.
For patients who underwent isolated AVR, had at least
mild preoperative MR, and had no disease of the mitral
apparatus (including MAC), the average change in MR
was 0.24 degrees per patient.TABLE 3. Quantitative change in mitral regurgitation in patients
undergoing aortic valve intervention
Change in MR per
patient
Patients with MR (n ¼ 399) 0.11 per patient
Patients with at least mild MR (n ¼ 289) 0.24 per patient
Patients with at least moderate MR (n ¼ 56) 0.54 per patient
MR, Mitral regurgitation.
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TABLE 4. Quantitative change in mitral regurgitation in patients
undergoing isolated aortic valve replacement
Change in MR per
patient
AVR only with at least mild MR (n ¼ 169) 0.28 per patient
AVR only, mild MR, no leaflet disease (n ¼ 135) 0.26 per patient
AVR only, mild MR, no Mitral disease (n ¼ 62) 0.24 per patient
MR, Mitral regurgitation; AVR, aortic valve replacement.
FIGURE 2. Change in MR as a function of the gradient across the aortic
valve. A, Simple linear regression analysis of the change in MR for each
patient according to the preoperative mean gradient across the aortic valve
was performed for the entire cohort of 462 patients. B, Simple linear regres-
sion analysis of the change in MR for each patient according to the net
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Aortic Valve Gradient
To evaluate whether the change in MR observed after re-
lief of aortic outflow tract obstruction is dependent on the
preoperative gradient across the aortic valve and presum-
ably the extent of pressure overload reduction with AVR,
we next performed simple linear regression analysis. The
change in MR for each patient after aortic valve interven-
tion was plotted as a function of preoperative mean gradient
across the aortic valve. When this analysis was performed
for the entire cohort of 462 patients (Figure 2, A), no clear
relationship between change in MR and preoperative
mean gradient across the aortic valve was observed
(R2¼ 0.0002). To evaluate whether the net change in gradi-
ent across the aortic valve after AVRmight influence the de-
gree of improvement in MR, we also obtained data on the
mean postoperative gradient across the aortic valve where
available (n¼ 335). The change in gradient across the aortic
valve was calculated by subtracting the mean preoperative
gradient from the mean postoperative gradient. The change
in MR for each patient after aortic valve intervention was
then plotted as a function of change in mean gradient across
the aortic valve, and linear regression analysis was per-
formed (Figure 2, B). No clear relationship between change
in MR and change in mean gradient across the aortic valve
was observed (R2 ¼ 0.0002).change in mean gradient across the aortic valve was performed.
AV, Aortic valve.
Predictors of Improvement of Mitral Regurgitation
Although the overall change in MR observed after relief
of aortic outflow tract obstruction was modest, some pa-
tients did have some degree of improvement in MR,
whereas others did not. To help identify factors that might
predict improvement in MR, patients who underwent aortic
valve intervention with mild or greater MR preoperatively
were evaluated for improvement in MR. Patients were di-
vided into groups depending on whether there was improve-
ment in MR (n¼ 137) or no improvement in MR (n¼ 150).
Preoperative and operative characteristics were compared
(Tables 5 and 6). In the group of patients who did not expe-
rience improvement in MR, a greater proportion of patients
had mildMR, whereas a greater proportion of patients in the
group that did experience improvement had greater than
mild degrees of MR. There were no significant differences
in other preoperative or operative characteristics examined,344 The Journal of Thoracic and Cardiovascular Surgincluding ejection fraction, mean aortic valve gradient,
mean pulmonary artery pressure, and left atrial diameter.DISCUSSION
Previous studies have shown significant variability in the
degree of improvement in MR after AVR.1 The most prom-
inent finding of our study is that there is little improvement
in MR after relief of aortic outflow tract obstruction by
AVR. In the entire cohort of 462 patients who were ana-
lyzed, there was a decrease of only 0.08 degrees of MR
per patient. Because this group contains patients with no
MR, it is not surprising that there was little net change in
MR for the group. However, when the same analysis was
performed for patients with MR (n ¼ 399) and patients
with at least mild MR (n ¼ 289), we found that the changeery c February 2013
TABLE 5. Comparison of baseline characteristics of patients with improvement inmitral regurgitation after aortic valve intervention versus those
with no improvement
Improved (n ¼ 137) No improvement (n ¼ 150) P value
Age (y) 74.7  9.5 74.5  9.9 P ¼ NS
Sex
Male 54.7% (n ¼ 75) 56.7% (n ¼ 85) P ¼ NS
Female 45.3% (n ¼ 62) 43.3% (n ¼ 65)
Race
Caucasian 90.5% (n ¼ 124) 91.3% (n ¼ 137) P ¼ NS
African American 8.0% (n ¼ 11) 4.7% (n ¼ 7)
Asian 0.0% (n ¼ 0) 1.3% (n ¼ 2)
Hispanic 0.0% (n ¼ 0) 1.3% (n ¼ 2)
Other/unspecified 1.5% (n ¼ 2) 1.3% (n ¼ 2)
Atrial fibrillation/flutter 24.1% (n ¼ 33) 28.7% (n ¼ 43) P ¼ NS
Diabetes 30.7% (n ¼ 42) 28.0% (n ¼ 42) P ¼ NS
Hypertension 81.0% (n ¼ 111) 81.3% (n ¼ 122) P ¼ NS
Previous MI 19.7% (n ¼ 27) 25.3% (n ¼ 38) P ¼ NS
Heart failure 82.5% (n ¼ 113) 90.0% (n ¼ 135) P ¼ NS
NYHA class
1 1.5% (n ¼ 2) 1.3% (n ¼ 2) P ¼ NS
2 26.2% (n ¼ 36) 32.7% (n ¼ 49)
3 43.0% (n ¼ 59) 42.7% (n ¼ 64)
4 10.2% (n ¼ 14) 13.3% (n ¼ 20)
Cerebrovascular disease 19.9% (n ¼ 26) 20.7% (n ¼ 31) P ¼ NS
Peripheral arterial disease 19.0% (n ¼ 22) 19.3% (n ¼ 29) P ¼ NS
Dialysis 2.2% (n ¼ 3) 2.0% (n ¼ 3) P ¼ NS
Creatinine 1.19  0.972 1.12  0.769 P ¼ NS
Ejection fraction (%) 54.0%  13.9% (n ¼ 135) 56.0% þ 13.6% (n ¼ 147) P ¼ NS
Mean aortic valve gradient (mm Hg) 45.4  16.0 (n ¼ 136) 43.4  16.5 (n ¼ 149) P ¼ NS
Mean pulmonary artery pressure (mm Hg) 27.2  9.7 (n ¼ 90) 27.9  10.5 (n ¼ 94) P ¼ NS
Left atrial diameter (cm) 4.46  0.85 (n ¼ 102) 4.50  0.83 (n ¼ 107) P ¼ NS
Degree of preoperative MR
Mild 49.6% (n ¼ 68) 70.7% (n ¼ 106) P ¼ .003
Mild-moderate 25.5% (n ¼ 35) 14.7% (n ¼ 22)
Moderate 21.9% (n ¼ 30) 14.7% (n ¼ 22)
Moderate-severe 2.2% (n ¼ 3) 0.0% (n ¼ 0)
Severe 0.7% (n ¼ 1) 0.0% (n ¼ 0)
Any structural MV disease 69.3% (n ¼ 95) 63.3% (n ¼ 95) P ¼ NS
MAC 62.0% (n ¼ 85) 53.3% (n ¼ 80) P ¼ NS
Moderate or worse MAC 24.1% (n ¼ 33) 30.0% (n ¼ 45) P ¼ NS
Leaflet abnormality 23.4% (n ¼ 32) 21.3% (n ¼ 32) P ¼ NS
MI, Myocardial infarction; NYHA, New York Heart Association; MV, mitral valve; MAC, mitral annular calcification; NS, not significant.
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when the same analysis was performed for patients
with MR (n ¼ 399) and patients with at least mild MR
(n ¼ 289), we found that the change in MR was roughly
a quarter of a degree per patient. Because some of these pa-
tients underwent concomitant CABG and some had evi-
dence of intrinsic mitral valve disease (most commonly
MAC), one could argue that these groups may include pa-
tients with some degree of ischemic MR or organic MR.
However, when patients who had at least mild MR who un-
derwent AVR only and had no evidence of any structural
mitral valve disease (including MAC) were considered,
there was still only a quarter of a degree of improvement
in MR per patient after AVR. Thus, regardless of theThe Journal of Thoracic and Cascenario, one can expect on average approximately a quarter
to a half of a degree reduction in MR at best with AVR for
AS. This observation argues in favor of an aggressive ap-
proach of concomitant MV repair during AVR when preop-
erative MR is present.
Several studies have found that the degree of improve-
ment in MR varies on the basis of cause.2,12 However,
Unger and co-investigators13 found that the cause of MR
was not predictive of improvement in MR. Our results sup-
port the finding by Unger and colleagues that the cause of
MR does not predict reduction in MR. Specifically, there
was no statistically significant difference in the proportion
of patients who had leaflet abnormalities, MAC, or any
structural MV disease between groups of patients whordiovascular Surgery c Volume 145, Number 2 345
TABLE 6. Comparison of operative characteristics of patients with
improvement in mitral regurgitation after aortic valve intervention
versus those with no improvement
Improved
(n ¼ 137)
No improvement
(n ¼ 150)
Nature of operation P ¼ NS
AVR 64.2% (n ¼ 88) 54.0% (n ¼ 81)
AVR þ CABG 21.9% (n ¼ 30) 32.0% (n ¼ 48)
AVR þ CABG þ other 2.2% (n ¼ 3) 2.7% (n ¼ 4)
AVR þ other 10.2% (n ¼ 14) 7.3% (n ¼ 11)
Aortic root replacement 0.7% (n ¼ 1) 0.7% (n ¼ 1)
Aortic root
replacement þ other
0.7% (n ¼ 1) 3.3% (n ¼ 5)
Incidence P ¼ NS
First cardiac surgery
operation
81.0% (n ¼ 111) 81.3% (n ¼ 122)
First reoperation 17.9% (n ¼ 24) 17.3% (n ¼ 26)
Second reoperation 1.5% (n ¼ 2) 1.3% (n ¼ 2)
Third reoperation 0.0% (n ¼ 0) 0.0% (n ¼ 0)
Urgency P ¼ NS
Elective 70.1% (n ¼ 96) 70.7% (n ¼ 106)
Urgent 27.0% (n ¼ 37) 27.3% (n ¼ 41)
Emergency 2.9% (n ¼ 4) 2.0% (n ¼ 3)
Cardiopulmonary bypass
time (min)
113  42.6 125  53.9 P ¼ NS
Valve type P ¼ NS
Bioprosthesis 96.3% (n ¼ 132) 95.3% (n ¼ 143)
Mechanical 3.6% (n ¼ 5) 4.7% (n ¼ 7)
Homograft 0.0% (n ¼ 0) 0.0% (n ¼ 0)
Implant size (mm) 23.8  2.1 23.5  2.2 P ¼ NS
AVR, Aortic valve replacement; CABG, coronary artery bypass grafting; NS, not sig-
nificant.
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who did not.
Aside from the cause of MR, a number of studies have
identified preoperative parameters that seem to predict im-
provement in MR after AVR. Parameters identified include
presence of coronary artery disease, absence of diabetes,
absence of pulmonary hypertension, left atrial diameter
less than 4.5 cm, presence of congestive heart failure,
lesser degrees of tricuspid regurgitation, absence of cere-
brovascular disease, and lower left ventricular (LV)
ejection fraction.4,14,15 Substantial variability exists in
these findings and is likely attributable to differences in
patient populations included in these studies, as well as
variability in factors examined and quantitation of these
variables. Our analysis was unable to confirm any of these
variables as predictors of improvement in MR after AVR.
One possibility is that the presence of functional MR after
AVR is a symptom of advanced underlying LV pathology.
For this reason, echocardiographic parameters of LV
dysfunction, particularly diastolic dysfunction, may serve
as better predictors of change in MR after AVR.
Preoperative MR severity was found to be a predictor
of improvement in our study and others.14,15 Although346 The Journal of Thoracic and Cardiovascular Surgmore severe degrees of MR predict improvement, more
than 40% of patients with moderate MR did not improve
in our analysis. Furthermore, the degree of improvement
in MR was modest. Specifically, only 0.56 degrees of
improvement in MR was observed in the subgroup of
patients who derived the greatest benefit. We found that
improvement in MR is difficult to predict on the basis of
simple preoperative characteristics.
The use of transcatheter aortic valve replacement (TAVR)
is becoming an important method of addressing aortic ste-
nosis in high-risk patients. Our observation that there is
only modest improvement in MR after relief of aortic out-
flow tract obstruction through open aortic valve or aortic
root replacement suggests that similar results would be ob-
served after TAVR. A recent study aimed at addressing
changes inMR after TAVR concurs with our observations.16
These results, in conjunction with our findings, suggest that
one can expect minimal reduction in MR after TAVR.
Study Limitations
The major limitation of this study is the retrospective na-
ture of the analysis. In addition, because LV remodeling
may occur over time after AVR, MR may subsequently
change over a longer period of time. One limitation of the
current study is the lack of long-term echocardiographic
data on patients. Of note, however, no changes were noted
in postprocedural MR, compared with early or late
follow-up in one study in which these parameters were ex-
amined.12 Another limitation of the use of intraoperative
echocardiography is that both cardioplegic arrest and load-
ing conditions may alter the degree of MR. For these rea-
sons, both short- and long-term postoperative assessment
of the degree of residual MR should be included in future
prospective studies. In addition, quantitative volumetric
measurements of the degree of MR also should be used in
such studies.
CONCLUSIONS
Repairing severe MR in virtually every scenario yields
significant benefit.17-22 Not treating intermediate levels
of MR in certain settings such as ischemic heart disease
portends a worse prognosis.23-25 MR in the setting of
aortic stenosis has not been as extensively studied, in
part because intermediate MR may decrease with relief
of LV pressure overload from AVR. Thus, the optimal
management of intermediate degrees of MR at the time
of AVR is undefined. Our data demonstrate that there is
little improvement in MR after AVR for aortic stenosis.
Furthermore, the degree of improvement in MR does not
depend on the preoperative gradient across the aortic
valve, nor does the extent of MR reduction correlate
with extent of LV pressure gradient reduction. Our
results indicate that it is difficult to predict which
patients will experience any improvement in MR afterery c February 2013
Kaczorowski et al Acquired Cardiovascular DiseaseAVR. Thus, our findings argue in favor of a more
aggressive approach to moderate MR at the time of
aortic valve intervention.A
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Dr Gabriel Aldea (Seattle, Wash). This is an important and
emerging topic, the incidence and significance of concomitant
MR in the presence of aortic stenosis. I have 2 brief comments
and several questions, and I will ask them sequentially.
The first comment is that you have shown these are coexistent
conditions, and aortic stenosis and MR are common. In fact,
28% of your original 802 patients had a concomitant mitral valve
surgery. That is a high incidence that supports a bias and institu-
tional belief that many of us have that severe residual MR ad-
versely affects survival and should be surgically addressed.
The second brief comment is, as you noted, we are dealing with
significant multiple overlapping pathologies that are confounding,
such as ischemic MR that can be seen in patients with CABG,
which may be reversible, and you are trying to sort out functional
MR from diseased mitral valve with primary pathology of the an-
nulus, leaflet, and cords. These are difficult to sort out, but you
managed to do this in your study by isolating patients with pure
aortic stenosis and specifically those without other mitral valve pa-
thology, and in those patients, the 56 (12%) of the 462 with mod-
erate or more MR, the magnitude of improvement when present
was modest. This observation mirrors what we now know from
the TAVR trials.
My first question is a methodological question. You have as-
sessed the impact of AVR on residual MR in the operating room.
I can see the logic and expediency of this, but what are the differ-
ences that you would expect with longer-term follow-up with se-
rial echocardiographic studies without the impact of immediate
postoperative changes and general anesthesia?
DrKaczorowski. In terms of longer-term follow-up, there are 2
studies in the literature that have looked at this retrospectively and
on a smaller scale. When looking at patients at least 1 year out, ac-
cording to an article published in The Annals of Thoracic Surgery
in 2007 and a more recent article published in The Journal of Tho-
racic and Cardiovascular Surgery with a longer-term follow-up,
significant changes were not observed in the proportion of
patients who experienced improvement in MR. It is an important
issue because there are 2 potential mechanisms that could be at
work. One is immediate relief of the pressure gradient across the
aortic valve. The second is longer-term remodeling that might
occur with the left ventricle, which might result in improvement
in the MR. These observations argue that the relief of the pressure
gradient across the aortic valve is probably more important thanrdiovascular Surgery c Volume 145, Number 2 347
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Dthe longer-term remodeling in terms of improvement in the MR.
You alluded to some of the data that have been reported in the
TAVR literature, and I think that is also what was seen in those re-
ports. I am aware of 2 studies that looked at change in MR in the
TAVR literature, and the immediate changes were not much differ-
ent than the longer-term changes. In these studies, MR was mea-
sured immediately postoperatively and then approximately 1
month afterward, and the investigators found that there were no
changes over that period of time. In the longer term, there is not
as much change as you might expect from ventricular remodeling,
and a good amount of the change is due to relief of that pressure
gradient across the aortic valve.
Dr Aldea. The second question is a mechanistic question. You
and others have noted that the presence of MR in a variety of sit-
uations, preceding and after CABG and now preceding AVR, has
a significant negative impact on long-term survival. You have also
shown that AV gradient does not correlate with the modest im-
provement in MR even if that is present. Given that, does the pres-
ence of nonstructural MR in the presence of symptomatic aortic
stenosis reflect the advanced underlying pathology or chronicity
or does it reflect other primary mitral valve issues? This is impor-
tant because you might be looking at the wrong parameters. Pa-
rameters of diastolic dysfunction might correlate more than
simply AV gradients. Ejection fraction and left atrial size may cor-
relate better with impact or lack therefore of AVR on MR.
Dr Kaczorowski. It is difficult to know, but I think we can say,
according to the mitral repair literature, that ongoing MR is cer-
tainly not a good thing. It leads to worse patient outcomes, and af-
ter mitral repair the persistence of MR has a detrimental effect on
patients. Repairing the MR seems to improve patient outcomes.
Data from studies on ischemic MR suggest that persistence of
some intermediate degrees of MR portends a worse long-term
prognosis. Whether repairing it makes a difference in that setting
is more difficult to sort out, but again, from what we know in the
literature, having ongoing long-standing MR is a bad thing. Ac-
cording to the mitral repair literature, repairing MR seems to mit-
igate some of those adverse effects of long-standing MR.
Dr Aldea. So let’s talk about that, which leads to the third clin-
ical question I have. Your conclusion suggests the more aggressive
medical approach even for moderate MR, particularly when it is
seen with concomitant aortic stenosis. This is a strong recommen-
dation and to actually broaden your presentation from a mere anal-
ysis of intraoperative echocardiographic MR associated with
AVR. You have an opportunity to sort that out because you can
analyze the immediate risk, the mortality, and the perioperative348 The Journal of Thoracic and Cardiovascular Surgmortality of the groups you have discussed (isolated AVR alone
compared with concomitant AVR and MV surgery) and look at
differences in survival over time. That is going to be particularly
important because it may affect the choice of therapy that is of-
fered to patients as we are looking at evolution of therapy choices
for surgical AVR surgery, surgical sutureless AVR, and transcath-
eter aortic valve surgery, as well as percutaneous mitral valve ap-
proaches, particularly in elderly and sick patients (eg, surgical
mitral valve repair, MitraClip with or without coronary sinus or
device intervention). I am interested to see how your data answer
the clinical relevance of residual MR in the presence of AS and
how minimal impact of AVR on MR is going to change your
group’s management recommendation, as a leading group in
TAVR nationally, in managing patients with aortic stenosis who
present with MR.
Dr Kaczorowski. Certainly. I think that more data are required
to answer that question. We do not have the mortality data that you
are asking about. What I can tell you is that the persistence of MR
portends aworse prognosis, and repairing it as we talked aboutmay
result in better patient outcomes. The approach to each of these pa-
tients has to be customized and dealt with on a per-patient basis.
That is, in a high-risk patient we know that double-valve surgery
carries greater operative risk. So patients who are at higher risk
and perhaps less likely to benefit may not be candidates for a dou-
ble-valve procedure, whereas younger healthier patients may be
more appropriate candidates to pursue the MR in this setting.
Moderator. Okay, Richard, 1 question.
Richard Shemin (Los Angeles, Calif). Okay, how about a yes or
no:Were these preoperative and postoperative measurements done
under anesthesia in the operating room or what were the time
points?
Dr Kaczorowski. I cannot give you a yes or no for that, but I
can tell you the preoperative echocardiograms were done within
6 months of the procedure. The postoperative echocardiogram
was done in the operating room. It was typically the immediate
postoperative transesophageal echocardiogram.
Dr Shemin. So we know that has a significant error rate. How
many of those patients actually went on to mitral valve repair or
replacement in follow-up?
Dr Kaczorowski. I do not have those data for you.
Dr Shemin. Do you measure the left atrial size and the mitral
valve annular size in your predictive model?
Dr Kaczorowski.We have the left atrial size, but I do not know
if we have the annular dimensions.
Dr Shemin. See? One question, 3 parts.ery c February 2013
